Cybrexa Therapeutics
Vishwas Paralkar has a strong background in scientific research and development. Vishwas joined Modifi Bio in 2022 as a Member of the Scientific Advisory Board. Before that, they worked at Cybrexa Therapeutics starting from 2017, where they held the position of Chief Scientific Officer. From 2010 to 2017, Vishwas served as the Chief Scientific Officer at Karos Pharmaceuticals. Prior to that, they had a long tenure at Pfizer Pharmaceuticals, starting in 1995. During their time at Pfizer, they held various roles including Director and Associate Research Fellow. Vishwas also worked as a Senior Research Scientist at SVP Pfizer from 1995 to 1998. Vishwas began their career as a Research Fellow at the National Institute for Medical Research in 1989.
Vishwas Paralkar pursued their education from 1984 to 1989 at Howard University, where they obtained a Ph.D. in Cell Biology/Biochemistry.